The Foreign Corrupt Practices Act – Special Challenges for the Pharmaceutical and Medical Device Industries

Practices: Life Sciences, Health Care

The government continues to make the pharmaceutical and medical device industries a central focus of its FCPA enforcement program.  Two partners from our Government Enforcement Practice Group will discuss the special challenges that global pharmaceutical and medical device companies face in today’s enforcement environment and provide some useful compliance advice to help avoid becoming entangled in a costly government investigation.
Cookie Settings